Effects of Polymer Encapsulated Glial Cell Line-Derived Neurotrophic Factor Secreting Cells on Odontoblast-like Cell Survival

Objective: Cells that are encapsulated into immunoprotective and implantable devices provide a means of enabling targeted, longterm, continuous, de novo synthesized delivery of very high levels of therapeutic molecules. In this study, we examined effects of polymer encapsulated glial cell line-derived neurotrophic factor (GDNF) secreting ARPE-19 cells on the in vitro viability of odontoblast-like cells (KN-3 cells) under normally lethal starvation conditions. Materials and methods: Devices (polymeric hollow fibers) were loaded with either GDNF-secreting ARPE-19 cells (GDNF-device) or non-modified ARPE-19 cells (ARPE-control device). KN-3 cell survival and function was quantified under starvation conditions when the cells were co-cultured with either control or GDNF devices. We further examined the specificity of GDNF by neutralizing the activity of GDNF with the soluble GDNF receptor (GFRα-1). Results: When KN-3 cells were co-cultured with either device under starvation, the cells exhibited a concentration gradient-dependent enhancement of survival in the area immediately surrounding the device. Similar survival benefits occurred when KN-3 cells were cultured in media previously used to maintain the cells encapsulated in the device. Because ARPE-19 cells also normally secrete low levels of VEGF, the maintenance medium from each device group was pretreated with soluble Flt-1 or soluble GFRα-1 to neutralize VEGF or GDNF. The survival of KN-3 cells was suppressed when cultured in VEGF-neutralized medium from ARPE-control devices, but not in that from GDNF-devices. In contrast, when GDNF was neutralized with soluble GFRα-1, the survival of KN-3 cells was intensely suppressed. Conclusion: These results suggest that GDNF delivered from encapsulated cells can augment the survival of odontoblast-like cells, and that the delivery of growth factors by encapsulated cells may be useful for enhancing pulp wound healing and regeneration. These data also pave the way for additional in vivo studies to determine the utility of this approach in regenerative endodontics.

[1]  L. Shea,et al.  Advances in islet encapsulation technologies , 2017, Nature Reviews Drug Discovery.

[2]  C. Ibáñez,et al.  Biology of GDNF and its receptors — Relevance for disorders of the central nervous system , 2017, Neurobiology of Disease.

[3]  B. Chan,et al.  Sustained Delivery of Bioactive GDNF from Collagen and Alginate-Based Cell-Encapsulating Gel Promoted Photoreceptor Survival in an Inherited Retinal Degeneration Model , 2016, PloS one.

[4]  M. Stampanoni,et al.  A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies. , 2016, Brain : a journal of neurology.

[5]  H. Christofk,et al.  Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy , 2015, Journal of Cell Science.

[6]  J. Cleveland,et al.  Spinal cord protection via alpha-2 agonist-mediated increase in glial cell-line-derived neurotrophic factor. , 2015, The Journal of thoracic and cardiovascular surgery.

[7]  Gorka Orive,et al.  Encapsulated cell therapy for neurodegenerative diseases: from promise to product. , 2014, Advanced drug delivery reviews.

[8]  R. Kramer,et al.  Differentiation of Human Skeletal Muscle Stem Cells into Odontoblasts Is Dependent on Induction of α1 Integrin Expression* , 2014, The Journal of Biological Chemistry.

[9]  Weng Tao,et al.  Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases. , 2012, Investigative ophthalmology & visual science.

[10]  D. Emerich,et al.  Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer , 2011, Gene Therapy.

[11]  P. Cooper,et al.  Effects of Glial Cell Line-derived Neurotrophic Factor on Dental Pulp Cells , 2011, Journal of dental research.

[12]  J. Sørensen,et al.  Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Göttingen minipig basal forebrain. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  Y. Tabata,et al.  Formation of dentinal bridge on surface of regenerated dental pulp in dentin defects by controlled release of fibroblast growth factor-2 from gelatin hydrogels. , 2009, Journal of endodontics.

[14]  K. Matsushita,et al.  Regeneration of dental pulp after pulpotomy by transplantation of CD31(-)/CD146(-) side population cells from a canine tooth. , 2009, Regenerative medicine.

[15]  T. Morotomi,et al.  Effects of lipopolysaccharide on newly established rat dental pulp-derived cell line with odontoblastic properties. , 2007, Journal of endodontics.

[16]  Mart Saarma,et al.  The GDNF family: Signalling, biological functions and therapeutic value , 2002, Nature Reviews Neuroscience.

[17]  L. Deng,et al.  Adenoviral-mediated GDNF protects bone marrow mesenchymal stem cells against apoptosis induced by hydrogen peroxide. , 2014, Bio-medical materials and engineering.

[18]  D. Emerich,et al.  Encapsulated cell-based biodelivery of meteorin is neuroprotective in the quinolinic acid rat model of neurodegenerative disease. , 2012, Restorative neurology and neuroscience.

[19]  J. D. de Vicente,et al.  Impaired dental cytodifferentiation in glial cell-line derived growth factor (GDNF) deficient mice. , 2002, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[20]  H. Hellmich,et al.  Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions , 1996, Mechanisms of Development.